Effect of Membrane Composition on Antimicrobial Peptides Aurein 2.2 and 2.3 From Australian Southern Bell Frogs  by Cheng, John T.J. et al.
552 Biophysical Journal Volume 96 January 2009 552–565Effect of Membrane Composition on Antimicrobial Peptides Aurein 2.2
and 2.3 From Australian Southern Bell Frogs
John T. J. Cheng,† John D. Hale,‡ Melissa Elliot,‡ Robert E. W. Hancock,‡ and Suzana K. Straus†*
†Department of Chemistry and ‡Centre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver,
British Columbia, Canada
ABSTRACT The effects of hydrophobic thickness and themolar phosphatidylglycerol (PG) content of lipid bilayers on the struc-
ture and membrane interaction of three cationic antimicrobial peptides were examined: aurein 2.2, aurein 2.3 (almost identical to
aurein 2.2, except for a point mutation at residue 13), and a carboxy C-terminal analog of aurein 2.3. Circular dichroism results
indicated that all three peptides adopt an a-helical structure in the presence of a 3:1 molar mixture of 1,2-dimyristoyl-sn-glycero-
3-phosphocholine/1,2-dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (DMPC/DMPG), and 1:1 and 3:1 molar mixtures of
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine/1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (POPC/POPG).
Oriented circular dichroism data for three different lipid compositions showed that all three peptides were surface-adsorbed at
low peptide concentrations, but were inserted into the membrane at higher peptide concentrations. The 31P solid-state NMR
data of the three peptides in the DMPC/DMPG and POPC/POPG bilayers showed that all three peptides signiﬁcantly perturbed
lipid headgroups, in a peptide or lipid composition-dependent manner. Differential scanning calorimetry results demonstrated
that both amidated aurein peptides perturbed the overall phase structure of DMPC/DMPG bilayers, but perturbed the POPC/
POPG chains less. The nature of the perturbation of DMPC/DMPG bilayers was most likely micellization, and for the POPC/
POPG bilayers, distorted toroidal pores or localized membrane aggregate formation. Calcein release assay results showed
that aurein peptide-induced membrane leakage was more severe in DMPC/DMPG liposomes than in POPC/POPG liposomes,
and that aurein 2.2 induced higher calcein release than aurein 2.3 and aurein 2.3-COOH from 1:1 and 3:1 POPC/POPG lipo-
somes. Finally, DiSC35 assay data further delineated aurein 2.2 from the others by showing that it perturbed the lipid membranes
of intact S. aureus C622 most efﬁciently, whereas aurein 2.3 had the same efﬁciency as gramicidin S, and aurein 2.3-COOH
was the least efﬁcient. Taken together, these data show that the membrane interactions of aurein peptides are affected by the
hydrophobic thickness of the lipid bilayers and the PG content.INTRODUCTION
Cationic antimicrobial peptides are an important class of
compounds that are being explored as alternatives to
currently used antibiotics, because of their unique property
of displaying few to no resistance effects (1–3). They are
ubiquitous in nature, and constitute an important part of
the immune defense system of many plants and animals.
For example, amphibians secrete a range of cationic antimi-
crobial peptides as part of their host-defense mechanism
(4,5). A number of these were studied extensively, and
include magainins (6–15), maculatins (16–21), brevinins
(22–27), and others, such as citropin 1.1 and aurein 1.2
from the Australian tree frogs Litoria citropa and Litoria
aurea (16–19,21,28–30), respectively. The latter peptide is
part of a larger family of peptides known as aurein peptides,
which range in length from 13–25 residues. Many aurein
peptides possess an amidated C-terminus and exhibit
broad-spectrum antimicrobial activity against Gram-positive
bacteria such as Bacillus cereus, Leuconostoc lactis,
S. aureus, and S. epidermis, as well as other disease-causing
agents, such as cancerous cells (29).
Aurein 1.2 is by far the most studied member of the aurein
peptide family. It is a 13-residue peptide, with a net positive
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0006-3495/09/01/0552/14 $2.00charge of þ1. Solution-state NMR and circular-dichroism
studies showed that it adopts an a-helical conformation in
membrane mimetic environments (30,31). Because the
length of aurein 1.2 is too short (~19.5 A˚) (16) to span fluid
lipid bilayers, it was proposed that this peptide interacts
primarily with the membrane interface, and promotes bilayer
damage by a detergent-like or carpet-like mechanism.
Recently, aurein 1.2 was shown to be an effective bacteri-
cidal agent against staphylococci and streptococci (32).
Moreover, it was found to have relatively low cytotoxicity,
and to act in synergy with other antibiotics such as minocy-
cline or clarithromycin. Because these antibiotics are hydro-
phobic, it is believed that the membrane perturbation induced
by aurein 1.2 facilitates the entry of minocycline or clarithro-
mycin into the membrane, making them more effective
(33,34). The ability of aurein 1.2 to perturb membranes
was recently examined in detail, using differential scanning
calorimetry and Fourier transform infrared spectroscopic
studies (35).
In our previous work, we examined two other members of
the aurein peptide family, i.e., aurein 2.2 (GLFDIVKKVVG
ALGSL-CONH2) and aurein 2.3 (GLFDIVKKVVGAIGS
L-CONH2), as well as an inactive version of aurein 2.3
with an anionic carboxy C-terminus (aurein 2.3-COOH).
Each of these peptides is 16 residues in length, with a net
doi: 10.1016/j.bpj.2008.10.012
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solution-state circular dichroism and 1H NMR spectroscopy,
it was demonstrated that the three aurein peptides adopt a
continuous a-helical structure in the presence of trifluoroe-
thanol (TFE), 1,2-dimyristoyl-sn-glycero-3-phosphocholine
(DMPC), and 1:1 DMPC/1,2-dimyristoyl-sn-glycero-
3-[phospho-rac-(1-glycerol)] (DMPG) (mol/mol) small uni-
lamellar vesicles (SUVs) (36). Further model membrane
studies, using oriented circular dichroism spectroscopy
(OCD), showed that aurein 2.2 and aurein 2.3 effectively
perturb the 1:1 DMPC/DMPG (mol/mol) bilayers (bacte-
rium-like membranes), while displaying minor effects on
DMPC bilayers (mammalian-like membranes) (36). In
contrast, aurein 2.3-COOH showed a decreased ability to
insert into DMPC/DMPG bilayers, but a slightly greater
ability to perturb DMPC bilayers (36).
To determine the mode of action of cationic antimicrobial
peptides in general, it is important to establish the nature of
the interaction of peptides with model membrane bilayers.
Over the years, a number of lipids have been used for such
studies: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) (e.g., MSI-78 and MSI-594) (37), 1,2-dimyris-
toyl-sn-glycero-3-phosphocholine (DMPC) (e.g., aurein
1.2) (19), 1,2-diphytanoyl-sn-glycero-3-phosphatidylcho-
line (DPhPC) (e.g., alamethicin) (38,39), and other diacyl-
phosphatidylcholine membranes (e.g., K2(LA)xK2) (40),
or lipid mixtures, such as POPC/1-palmitoyl-2-oleoyl-sn-
glycero-3-[phospho-rac-(1-glycerol)] (POPG) (e.g., MSI-
78 and MSI-594) (37) and DMPC/DMPG (e.g., PGLa)
(41), to name but a few. To describe peptide-lipid interac-
tions completely, a range of parameters such as peptide/lipid
ratio, membrane composition, temperature, hydration,
buffer composition (42), and lipid phase (39) must be taken
into account. Most importantly, the results from such
studies must be correlated with assays performed on live
bacteria, e.g., the DiSC35 assay that assesses the depolariza-
tion of cytoplasmic membranes, to determine biological
relevance.
To elucidate a more comprehensive mechanism of action
for aurein 2.2 and aurein 2.3, we examined the effect of lipid
bilayer thickness and molar phosphatidylglycerol (PG)
content on the ability of peptides to perturb membranes,
using the most widely used lipid mixtures, i.e., 1:1 and 3:1
mixtures of DMPC/DMPG and POPC/POPG. Given that
the two peptides differ in sequence only at position 13, we
wanted to establish whether the modest change in going
from leucine to isoleucine had any effect on peptide-lipid
interactions. This was of particular interest because the orig-
inal reports indicated that aurein 2.2 was four times more
active than aurein 2.3, as determined by minimal inhibitory
concentrations (MICs) (30). Although in our hands the MICs
for these two peptides were closer to one another (36), and
although it is well-known that some variability exists in the
determination of MICs (e.g., variations by factors of 2), it
is still important to understand what effect the amino acidsequence (e.g., hydrophobicity or electrostatics) exerts on
structure and membrane interaction, and how that, in turn,
affects antimicrobial activity (43–47). As in our previous
study, we used aurein 2.3-COOH, an inactive version of aur-
ein 2.3, as a benchmark.
Here, we used solution circular dichroism (CD) spectros-
copy to determine whether any structural changes of the
three aurein peptides occurred in different lipid vesicles.
To assess how activity may be influenced by different
membrane composition, we determined the interaction
between three aurein peptides and various lipid bilayers,
using OCD, 31P NMR spectroscopy, and differential scan-
ning calorimetry (DSC). We conducted calcein release
assays (using DMPC/DMPG and POPC/POPG model
membranes) and 3,30-dipropylthiadicarbocyanine iodide
(DiSC35) assays (using S. aureus C622) to examine whether
leakage is sequence-dependent or lipid composition-depen-
dent. Overall, these data should allow us to determine the
best bacterial model membranes to study this family of
cationic antimicrobial peptides, and to understand better
how sequence modulates function.
MATERIALS AND METHODS
Materials
Fmoc-protected amino acids, Wang and Rink resin, and 2-(1H-benzotriazol-
1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) were
purchased from Advanced ChemTech (Louisville, KY). We obtained N-hy-
droxybenzotiazhole (HOBt) from Novabiochem (San Diego, CA). We
purchased N,N-dimethylformamide (DMF), dichloromethane (DCM), aceto-
nitrile (AcN), and potassium nitrate from Fisher Chemicals (Nepean, Ontario,
Canada). The N,N-diiopropylethylamine (DIEA), trifluoroacetic acid (TFA),
ethane dithiol (EDT), and triethylsilane (TES) were obtained from Sigma-
Aldrich (St. Louis, MO). Mylar plates were made by cutting Melinex Teijin
films from Dupont (Wilton, United Kingdom). The 1,2-dimyristoyl-sn-glyc-
ero-3- phosphocholine (DMPC), 1,2-dimyristoyl-sn-glycero-3-[phospho-rac-
(1-glycerol)] (DMPG), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC), and 1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]
(POPG) were purchased from Avanti Polar Lipids (Alabaster, AL), and
were obtained dissolved in chloroform. We purchased bis[N,N
bis(carboxymethyl)aminomethyl]fluorescein (calcein) and 3,30- DiSC35 from
Sigma-Aldrich.
Peptide synthesis
Aurein 2.2, aurein 2.3, and aurein 2.3-COOH were synthesized as previously
described (36), using a peptide synthesizer from CS Bio Co. (Menlo Park,
CA) and in situ neutralization Fmoc chemistry, with Rink or Wang resin,
as appropriate. The C-terminal Leu was double-coupled (i.e., allowed to
couple to the resin for 60 min, washed, and allowed to couple to resin for
a further 60 min before the next step in the peptide synthesis), to improve
the yield.
Puriﬁcation
The crude peptide product was purified by preparative reverse phase high-
performance liquid chromatography on a Waters (Mississauga, Ontario,
Canada) 600 system with 229-nm ultraviolet detection, using a Phenomenex
(Torrance, CA) C4 preparative column (20.0 mm, 2.1 cm  25.0 cm), as
previously described (36). The identity of products was verified using
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described (36), and confirmed to be ~98–99% pure.
Solution CD sample preparation
Solution CD samples with a constant peptide concentration of 2.0 mM were
prepared in different peptide/lipid (P/L, either DMPC/DMPG or POPC/
POPG) molar ratios of 1:15, 1:50, and 1:100 (or 6.7, 2.0, and 1.0 mol %
of peptide with respect to lipids). Appropriate amounts of lipids in chloro-
form were dried, using a stream of air to remove most of the chloroform,
and vacuum-dried overnight in a 5.0-mL round-bottom flask. After adding
500 mL of ddH2O and 0.1 mmol (0.16 mg) of peptide to dried lipids, the
mixture was sonicated in a water bath for a minimum of 30 min (until the
solution was no longer turbid), to ensure lipid vesicle formation. For all
samples, corresponding background samples without peptides were
prepared for spectral subtraction.
Mechanically oriented sample preparation
Solid-state NMR samples were prepared for three different P/L molar
ratios: 1:15, 1:80, and 1:120, following procedures similar to those re-
ported (48,49). The amount of lipids (dissolved in chloroform) was kept
constant at 9.59 mmol. The lipid was dried using a stream of air to remove
most of the chloroform, and vacuum-dried overnight in a 5-mL round-
bottom flask. Then the appropriate amount of peptide was added, and
the mixture was redissolved in 400 mL of ddH2O by sonication. The
mixture was deposited in 10-mL portions repeatedly onto nine Mylar plates
placed in a petri dish. Between depositions, most of the ddH2O was evap-
orated before the next portion was deposited onto the plate. The plated
samples were then placed in a 93% relative humidity chamber, and were
indirectly hydrated by incubating inside a dessicator at 37C for 5 days
(DMPC/DMPG) or 7 days (POPC/POPG). The humidity of samples was
verified by visual inspection (well-hydrated samples are translucent).
The degree of alignment was verified by 31P solid-state NMR. Consistent
sample preparation was verified by preparing 2–3 samples for each lipid
composition and peptide concentration. Finally, plated samples were wrap-
ped in a thin layer of parafilm, and placed in plastic sheathing before data
acquisition.
Oriented CD samples were prepared in a similar fashion to that described
above. The peptide amount was kept constant at 0.5 mmol (0.81 mg), and
mixed with appropriate molar ratios of lipids, i.e., 1:15, 1:30, 1:40, 1:80,
and 1:120 P/L ratios (or 6.67, 3.33, 2.50, 1.25, and 0.83 mol % of peptide
with respect to lipids), and sonicated in 2 mL of ddH2O. Each mixture
was deposited in 90-mL portions onto 3 cm  1 cm and 1-mm-thick quartz
slides, cleaned thoroughly with ddH2O and ethanol before sample prepara-
tion. Clear layers of samples were evident on the slides after indirect hydra-
tion of the samples. Before CD spectral acquisition, each sample was
covered with a second slide with a spacer (six layers of stacked parafilm,
in a rectangular 3 cm  1 cm frame with a 2-mm width) in between.
Circular dichroism
Solution and oriented CD experiments were performed using a J-810 spec-
tropolarimeter (Jasco, Victoria, British Columbia, Canada) at 30C, as previ-
ously described (36). Briefly, spectra were obtained over a wavelength range
of 185–250 nm, using continuous scanning mode with a response of 1 s with
0.5-nm steps, a bandwidth of 1.5 nm, and a scan speed of 20 nm/min. The
signal/noise ratio was increased by acquiring each spectrum over an average
of three scans. Finally, each spectrum was corrected by subtracting the back-
ground from the sample spectrum. The temperature was kept constant by
means of a water bath.
NMR spectroscopy
Solid-state 31P NMR experiments on mechanically aligned lipid bilayer
samples were performed on a 500-MHz NMR spectrometer (Bruker Bio-
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frequency of 202.48 MHz, as previously reported (36). The 90 pulse
was set to 12.5 ms (DMPC/DMPG) or 10.5 ms (POPC/POPG), and a 3-s
recycle delay was used. Spectra were acquired using 2048 scans, and were
processed without any line-broadening.
Calcein release assays
Appropriate amounts of lipids for a specific lipid mixture were weighed and
dissolved in chloroform (1–2 mL) in a glass vial. Chloroform was then evap-
orated under a stream of nitrogen, and the lipid mixture was further dried
under vacuum for at least 2 h. Calcein resuspending buffer was prepared
by dissolving 62 mg of calcein in 1 mL of 5.0 mM HEPES buffer,
pH 7.5 (final concentration, 100 mM). The NaOH was added in small
aliquots until calcein dissolved, to yield a dark orange solution. Calcein
release buffer was then added to the lipid mixture, which underwent five
cycles of freezing and thawing. Liposomes were extruded through two
double-stacked 0.1-mm membranes. The extruded calcein-entrapped lipo-
somes were then separated from free calcein in solution, using a Sephadex
G50 column (GE Healthcare, Piscataway, NJ) which was rehydrated over-
night in 20 mM HEPES, 150 mM NaCl, and 1.0 mM EDTA, pH 7.4.
The rehydrating buffer was also used as the eluting buffer.
Calcein-free liposomes were prepared using the same procedure, but
without using calcein in the resuspending buffer. We prepared 1.5 mL of
the calcein-free liposomes because of their greater usage during the assay.
The lipid mixture was resuspended in 20 mM HEPES, 150 mM NaCl,
and 1.0 mM EDTA, pH 7.4, and extruded as above, without running through
the Sephadex G50 column.
The calcein release assay was performed by combining 2 mL of 20 mM
HEPES, 150 mM NaCl, 1.0 mM EDTA (pH 7.4), 3.75 mL of calcein-
entrapped liposomes, and 7.5 mL of calcein-free liposomes in a cuvette,
with slow stirring. Fluorescence was measured using a 640-10S spectroflu-
orimeter (PerkinElmer, Waltham, MA), with an excitation wavelength of
490 nm and an emission wavelength of 520 nm. A slit width of 6 nm
was generally used, but could be adjusted to achieve maximum fluores-
cence. Baseline fluorescence was established for ~100 s. Maximum fluores-
cence was determined by adding 0.1% Triton X-100 as a control. After
establishing baseline and maximum fluorescence, the peptides of interest
were added to perform the assay. Gramicidin S was used as a positive
control.
DiSC35 assays
The ability of aurein peptides to depolarize the cytoplasmic membrane of
S. aureus C622 was determined, using the membrane potential sensitive
dye DiSC35. The C622 was grown to mid-logarithmic phase in Luria Broth
medium, centrifuged, washed in 5 mM HEPES and 20 mM glucose, and
resuspended in the same buffer to a final OD600 of 0.05. A final concen-
tration of 200 mM KCl was added to the cells and left for 30 min at
room temperature, to equilibrate cytoplasmic and external Kþ concentra-
tions, before DiSC35 was added at a final concentration of 0.8 mM for
30 min.
Changes in fluorescence resulting from disruption of the membrane
potential were measured up to 5 min, using a 640-10S spectrofluorimeter
(PerkinElmer), with an excitation wavelength of 622 nm and an emission
wavelength of 670 nM after the addition of each aurein peptide at 1 ,
2 , and 5  MIC (as previously ascertained) (36) to 2-mL cell suspension
in a 1-cm quartz cuvette. Aurein 2.3-COOH was only tested at 1  MIC
because of its high MIC. All membrane permeabilization results were
compared to gramicidin S, used as a positive control.
Differential scanning calorimetry
Each aurein peptide was added at a 1:15 aurein/lipid molar ratio to multi-
lamellar vesicles of 1:1 DMPC/DMPG or 1:1 POPC/POPG (25 mg/mL)
resuspended in HEPES buffer (20 mM HEPES, pH 7.0, 100 mM
Aurein Peptide-Membrane Interaction 555NaCl). Samples were degassed for 5 min before loading the sample into
a VP-DSC or multicell DSC (Calorimetry Sciences, South Provo, UT),
located at the University of British Columbia Centre for Biological Calo-
rimetry. Samples were heated and cooled over a temperature range of
1–70C at a rate of 1.00C/min (DMPC/DMPG), or 20–70C at a rate
of 0.33C/min (POPC/POPG). The resulting data were converted to units
of molar heat capacity, after baseline correction by subtracting a blank
buffer scan.
RESULTS
Secondary structure of aurein peptides
by solution CD spectroscopy
Our previous studies showed that the aurein 2.2, aurein 2.3,
and aurein 2.3-COOH peptides adopt an a-helical structure
in the presence of TFE, DMPC, and 1:1 DMPC/DMPG
(mol/mol) SUVs (36). To verify that these peptides remain
structured in the different lipid environments probed here,
solution CD experiments were performed, using different
lipid mixtures and P/L ratios.
Fig. 1 shows the solution CD results of the three aurein
peptides in 1:1 POPC/POPG SUVs. Additional solution
CD results of the three aurein peptides in 3:1 DMPC/
DMPG and 3:1 POPC/POPG SUVs are included in the Sup-
porting Material (Fig. S1). All spectra consisted predomi-
nantly of a maximum at 190 nm and two minima at 210 nm
and 222 nm, which are characteristic of a-helical structure.
All spectra were fitted using three different programs,
CDSSTR (50), CONTINLL (51), and SELCON3 (52–54),
using either the full data set or half the data set (using only
points at every 1 nm in a range of 190–260 nm) to estimate
error (Table S1). The results demonstrate that all three aurein
peptides adopt close to 100% a-helical conformation at high
P/L ratios (as also found in 50% TFE/H2O; Table S1). As re-
ported previously (36), similar intensities were evident for all
P/L molar ratios studied (P/L ¼ 1:15, 1:50, and 1:100) for
3:1 DMPC/DMPG, indicating that maximum binding of
the peptide to lipid vesicles occurred. Saturation would be
observed with a combination of signals from both a-helical
and random-coil structures (19). For POPC/POPG (1:1 or
3:1), on the other hand, the helical content increased with
increased peptide concentrations, indicating that high
concentrations are needed to achieve maximum binding.
Overall, the data show that the three aurein peptides were
dependent on the molar concentrations or types of phospho-
lipids examined.
Membrane insertion states of aurein peptides,
using OCD spectroscopy
Understanding the interactions of aurein peptides with
different model membranes is crucial in elucidating the
effects of membrane composition on the extent of peptide
insertion into lipid bilayers. We performed OCD experiments
to investigate the peptide insertion profiles in different lipid
bilayers. For both OCD and 31P solid-state NMR, samples-30
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FIGURE 1 Solution CD spectra of aurein peptides in 1:1 POPC/POPG
(mol/mol) SUVs: (a) aurein 2.2; (b) aurein 2.3; and (c) aurein 2.3-COOH
(solid black line, P/L ¼ 1:15; dotted line, P/L ¼ 1:50; solid gray line, P/L ¼
1:100). Spectra indicate that aurein peptides adopt an a-helical conformation
in the presence of POPC/POPG SUVs. Data for additional lipid composi-
tions can be found in the Supporting Material. The percentage of a-helical
content is reported in Table S1.
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556 Cheng et al.were prepared in a similar fashion, so that the data sets could
be compared directly, and so that we could verify that
samples were aligned. All experiments were conducted at
30C (liquid crystalline phase), for consistent comparisons
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FIGURE 2 Oriented CD spectra of aurein peptides in 1:1 POPC/POPG
(mol/mol) bilayers: (a) aurein 2.2; (b) aurein 2.3; and (c) aurein 2.3-
COOH. P/L molar ratios ¼ 1:15 (blue), 1:30 (green), 1:40 (red), 1:80
(black), and 1:120 (gray). Spectra were normalized such that intensities of
all spectra at 222 nm are the same. The spectra show that peptides insert
into 1:1 POPC/POPG (mol/mol) bilayers at threshold P/L molar ratios
between 1:80 and 1:120 for aurein 2.2, between 1:40 and 1:30 for aurein
2.3, and between 1:15 and 1:30 for aurein 2.3-COOH. Data for additional
lipid compositions can be found in the Supporting Material.
Biophysical Journal 96(2) 552–565with our previous study. In addition, experiments were
repeated at least twice, to ensure reproducibility of the results.
Fig. 2 shows OCD results for the aurein peptides in 3:1
DMPC/DMPG, 1:1 POPC/POPG, and 3:1 POPC/POPG
(mol/mol) bilayers as a function of P/L ratio. Spectra were
scaled so that the minimum at 222 nm had the same inten-
sity. The spectra in Fig. S2, a–c, showed that the three aur-
ein peptides inserted (inserted, I-state; or tilt, T-state) into
a 3:1 DMPC/DMPG bilayer at threshold P/L molar ratios
between 1:40 and 1:80, and became surface-adsorbed
(S-state) at P/L ratios >1:80 (mol/mol). This is in contrast
to previously reported OCD data in 1:1 DMPC/DMPG
(mol/mol) bilayers (36), where all three peptides were
already in the I-state or T-state at P/L ratios of 1:120. For
1:1 POPC/POPG (mol/mol) bilayers (Fig. 2, a–c, or
Fig. S2, d–f), each peptide inserted differently: the threshold
P/L molar ratio was between 1:80 and 1:120 for aurein 2.2,
between 1:40 and 1:30 for aurein 2.3, and between 1:15 and
1:30 for aurein 2.3-COOH. Finally, the spectra in Fig. S2,
g–i, show that the three aurein peptides inserted into the 3:1
POPC/POPG bilayer at threshold P/L molar ratios between
1:40 and 1:80.
The data illustrate that both molar PG content and bilayer
thickness played a role in peptide insertion profiles. A
decrease in molar PG content and an increase in bilayer
thickness progressively reduced the insertion ability of the
amidated peptides. High molar PG content and increased
bilayer thickness resulted in an inability of aurein
2.3-COOH to insert into 1:1 POPC/POPG bilayers, except
at high peptide concentrations. Because the DMPC/DMPG
and POPC/POPG bilayer hydrophobic thickness are
~26.5 A˚ (55,56) and ~39 A˚ (57) in the liquid crystalline
phase, respectively, the three aurein peptides would not
have sufficient peptide length (hydrophobic length, ~24 A˚)
to span the lipid bilayer entirely, particularly in the long-
chained POPC/POPG bilayers. Unfavorable electrostatic
interactions between the negatively charged C-terminus
and the negatively charged PG headgroups probably explain
the high aurein 2.3-COOH peptide concentrations needed to
permit insertion into the lipid bilayers at increased molar PG
content (43).
Lipid headgroup perturbation by aurein peptides
with 31P solid-state NMR spectroscopy
We recorded 31P NMR spectra for all peptides in 4:1 DMPC/
DMPG (mol/mol) (Fig. 3) and 4:1 POPC/POPG (mol/mol)
(Fig. 4) bilayers. These lipid compositions were chosen
because in both cases, all three peptides show similar
concentration-dependent insertion profiles (as in the 3:1
cases presented above). The 31P NMR experiments were
conducted to determine whether the insertion of peptides was
accompanied by a perturbation of the lipid headgroups,
and whether this membrane disruption occurred via a
barrel-stave, carpet, or toroidal pore (15,58–61), a micellar
dc
b
a
1:120 Peptide:Lipid (mol/mol)1:80 Peptide:Lipid (mol/mol)1:15 Peptide:Lipid (mol/mol)
50 0ppm 50 0ppm 50 0ppm
FIGURE 3 Solid-state 31P NMR spectra
of mechanically aligned 4:1 DMPC/DMPG
(mol/mol) bilayers containing three aurein
peptides: (a) DMPC/DMPG bilayers alone,
or (b) aurein 2.2, (c) aurein 2.3, and (d) aur-
ein 2.3-COOH. For the 1:15 P/L ratio, we
used 1.03 mg of peptide. For the 1:80 P/L
ratio, we used 0.19mg of peptide. For the
1:120 P/L ratio, we used 0.13 mg of peptide.
Spectra were recorded using 2048 scans at
30C, oriented such that the bilayer normal
was parallel to the external magnetic field.
Spectra were processed without any line-
broadening.
Aurein Peptide-Membrane Interaction 557aggregate channel (62,63), or a detergent-like mech-
anism (42).
In Fig. 3 a, in the absence of aurein peptides, a single 31P
spectral peak was observed at ~30 ppm. This finding illus-
trates that the phosphorus headgroups of 4:1 DMPC/
DMPG (mol/mol) bilayers were well-aligned, with the
bilayer normal parallel to the magnetic field. The presence
of peptides significantly changed the physical state of
DMPC/DMPG bilayers (Fig. 3, b–d). The peak at 30 ppm
disappeared when the amidated peptides were added to
the DMPC/DMPG bilayers, and a new, sharp, narrow
peak (with small powder-pattern signals) appeared, and
shifted to 0 ppm. This indicates that the phosphorus head-
groups of 4:1 DMPC/DMPG (mol/mol) mixtures were
highly curved in the presence of aurein 2.2 and aurein
2.3. Indeed, a number of other solid-state NMR studies
of antimicrobial peptides (12,64–66) demonstrated that
the presence of a peak at 0 ppm is indicative of either small
lipid vesicle/micelle formation or a different lipid-phase
formation. When aurein 2.3-COOH was added at high
concentrations, the spectrum displayed a similar single,
narrow, upfield-shifted peak (Fig. 3 d). However, at low
concentrations of aurein 2.3-COOH, the peak at 30 ppm
did not disappear completely. This finding suggests that
partial alignment was still maintained, and complete desta-
bilization of the lipid bilayers did not occur. The orienta-
tion of bilayer headgroups was not affected as significantly
by aurein 2.3-COOH at low P/L molar ratios. This findingwas consistent with our current (Fig. S2) and previous (36)
OCD results, i.e., that aurein 2.3-COOH does not insert
readily into the DMPC/DMPG bilayers at a 1:120 P/L
molar ratio.
In contrast to DMPC/DMPG bilayers, the aurein peptides
affected the thicker 4:1 POPC/POPG (mol/mol) bilayers
differently (Fig. 4). In the absence of peptides, spectra con-
sisted primarily of a single resonance at 30 ppm, which again
indicated that the lipid bilayers were aligned with their
normal parallel to the magnetic field (Fig. 4 a). The minor
peak at10 ppm represented the signal from a small percent-
age of unaligned bilayer headgroups, as observed in other
studies (65,66). In the presence of amidated aurein peptides,
the spectra showed an increased contribution from unaligned
31P headgroups and a broadened peak at 30 ppm. In addition,
a powder-pattern signal was also observed at10 to 30 ppm,
indicative of random headgroup orientations (Fig. 4, b and
c). These changes in the spectra occurred for all P/L molar
ratios and both aurein 2.2 and aurein 2.3, suggesting no
obvious dependence on peptide sequence and concentration.
When aurein 2.3-COOH was added at high concentrations,
the spectrum seemed similar to its amidated counterparts.
At low peptide concentrations, however, the two individual
peaks at 10 ppm and 30 ppm disappeared, and broadened
powder-pattern signals were evident. This finding may indi-
cate that aurein 2.3-COOH perturbed the phosphorus head-
groups in a way slightly different from that of amidated
peptides at low peptide concentrations (Fig. 4 d). The
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FIGURE 4 Solid-state 31P NMR
spectra of mechanically aligned 4:1
POPC/POPG (mol/mol) bilayers con-
taining three aurein peptides: (a)
POPC/POPG bilayers alone, or contain-
ing (b) aurein 2.2, (c) aurein 2.3, and (d)
aurein 2.3-COOH. For the 1:15 P/L
ratio, we used 1.03 mg of peptide. For
the 1:80 P/L ratio, we used 0.19 mg of
peptide. For the 1:120 P/L ratio, we
used 0.13 mg of peptide. Spectra were
recorded using 2048 scans at 30C,
oriented such that the normal bilayer
was parallel to the external magnetic
field. Spectra were processed without
any line-broadening.
558 Cheng et al.underlying powder pattern indicates that aurein peptides may
disorder the bilayer headgroups by formation of a toroidal
pore (15,58–61). The extent of membrane perturbation was
not found to be concentration-dependent or peptide-specific
(at least for the amidated versions).
Lipid-chain perturbation by aurein peptides,
using DSC
Observations of phase-transition changes provide information
on the overall phase structural integrity of lipid membranes in
the presence of antimicrobial peptides. We performed DSC
experiments to determine whether aurein 2.2 and aurein 2.3
affected the lipid chains, and we observed how these peptides
disrupted the phase structure of lipid membranes.
Fig. 5 a shows DSC thermograms of 1:1 DMPC/DMPG
(mol/mol) liposomes in the absence and presence of aurein
2.2, aurein 2.3, and aurein 2.3-COOH (P/L, 1:15). In the
absence of peptides, the thermogram consisted of a pretransi-
tion peak at 17.5C and a main phase transition peak at
24.5C, consistent with findings in the literature (67). In the
presence of amidated peptides, the pretransition peak re-
mained similar, whereas the main-phase transition peak
broadened and was almost completely abolished. This
Biophysical Journal 96(2) 552–565finding indicated that both aurein 2.2 and aurein 2.3 disrupted
lipid membranes severely, such that only a small lamellar-
liquid crystalline coexistence regime remained. For aurein
2.3-COOH, the main transition peak was severely broadened
as well, but not to the extent of the amidated peptides.
The broadened main-phase transition peak was also an indi-
cation of membrane curvature in the presence of peptides,
consistent with the 31P NMR data presented above for 4:1
DMPC/DMPG. A similar pretransition peak for the amidated
peptides indicates that the low-temperature phase domains
remained intact, suggesting that these peptides did not affect
the low-temperature phase domains significantly.
Fig. 5 b shows a thermogram of 1:1 POPC/POPG (mol/
mol) in the absence and presence of aurein 2.2, aurein 2.3,
and aurein 2.3-COOH (P/L, 1:15). In the absence of
peptides, the thermogram exhibited a single main-phase tran-
sition peak at 2C. In the presence of aurein 2.2, the tran-
sition peak shifted to a slightly higher temperature (1C).
In the presence of aurein 2.3, however, the transition temper-
ature did not change significantly. Finally, in the presence
of aurein 2.3-COOH, the transition temperature was 3C.
For all peptides, the transition peak intensity was slightly
different when the peptides were present. This finding indi-
cates that both amidated aurein peptides did not have
pronounced effects on the chain-melting event, and most
likely perturbed the headgroups more than the acyl chains.
Together with the 31P NMR data, these findings indicate
that aurein peptides most likely induce toroidal pore forma-
tion (i.e., either a distorted toroidal or localized membrane
aggregate model) in POPC/POPG bilayers.
Membrane leakage induced by aurein peptides
in model membranes, as determined in calcein
release assays
Given the results above, calcein release assays were used to
further determine to what extent the aurein peptides cause
membrane disruption. In general, the assay probes the increase
in fluorescence when the fluorophore (calcein) is released as
a result of membrane leakage. Gramicidin S, a cyclic antimi-
crobial peptide, acted as positive control in these assays. The
units of fluorescence were arbitrary, and set to a range of
0–1000. The assay was performed for a minimum of 300 s.
Table 1 summarizes relative percentages of aurein
peptide-induced calcein release with reference to the positive
control 0.1% Triton-X (set to 100%) at different P/L molar
ratios in different membranes. The three aurein peptides
caused significant calcein release at 1:15 P/L molar ratios,
and only minimal (%6%) release at lower concentrations.
All three aurein peptides caused nearly 100% calcein release
from 3:1 DMPC/DMPG liposomes at high peptide concen-
trations. In POPC/POPG liposomes, on the other hand, the
aurein peptides were less effective at causing membrane
leakage. Indeed, at a 1:15 P/L molar ratio, aurein 2.2 induced
the highest calcein release (27% and 36% in 1:1 and 3:1
POPC/POPG, respectively), whereas aurein 2.3 caused
a slightly lower calcein release than did aurein 2.3-COOH
from POPC/POPG liposomes (Table 1). It is noteworthy
that in 3:1 POPC/POPG, aurein 2.2 is a factor of 2–3 times
more effective at perturbing liposomes that aurein 2.3 and
aurein 2.3-COOH, which are equally effective. This finding
suggests that changing the nature of the C-terminus has little
effect on the capacity of these peptides to perturb model
membranes. At 1:80 and 1:120 P/L ratios, all aurein peptides
did not significantly disrupt 1:1 and 3:1 POPC/POPG lipo-
somes, consistent with our OCD results.
Fig. 6 a shows the calcein release assay results of aurein
peptides in 3:1 DMPC/DMPG (top), 1:1 (middle), and 3:1
POPC/POPG (bottom) (mol/mol) liposomes at 1:15 P/L
molar ratio. No obvious difference in the percentage of cal-
cein released was evident, compared with 3:1 DMPC/DMPG
(mol/mol) membranes in the presence of the peptides. When
added to 1:1 and 3:1 POPC/POPG (mol/mol) membranes,
aurein 2.2 induced higher calcein release than did the two
aurein 2.3-related peptides. Surprisingly, aurein 2.3-COOH
induces more leakage that aurein 2.3 at steady state
(t >200s), although aurein 2.3 perturbs membranes better
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FIGURE 5 DSC thermograms of (a) 1:1 DMPC/DMPG (mol/mol) and
(b) 1:1 POPC/POPG (mol/mol) liposomes in the absence (light gray solid
line) and presence of aurein 2.2 (black solid state), aurein 2.3 (dark gray
solid line), and aurein 2.3-COOH (gray) at a 1:15 P/L molar ratio.
TABLE 1 Percentage of calcein released relative to 0.1% Triton-X (deﬁned as 100%) from 3:1 DMPC/DMPG, and 1:1 and 3:1 POPC/
POPG (mol/mol) liposomes, in presence of aurein 2.2, aurein 2.3, and aurein 2.3-COOH
Peptides Aurein 2.2 Aurein 2.3 Aurein 2.3-COOH
P/L ratio 1:15 1:80 1:120 1:15 1:80 1:120 1:15 1:80 1:120
3:1 DMPC/PG 92% 87% 93%
1:1 POPC/PG 27%  2% 4% 2% 18%  2% 3% 3% 21%  5% 1% 2%
3:1 POPC/PG 36%  2% 4% 1% 12%  3% 6% 1% 16%  5% 1% 2%
Errors associated with measurements were determined for P/L ratio of 1:15 in 1:1 and 3:1 POPC/POPG from repeated measurements, and are given here.
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initially. Fig. 6 b shows the concentration dependence of aur-
ein-induced calcein release for 1:1 (middle) and 3:1 POPC/
POPG (bottom) (mol/mol) liposomes. The percentage of
calcein released increased as the peptide concentration
increased for all aurein peptides. At low peptide concentra-
tions, no difference was evident between peptides within
the margin of error (2–5%) of the experiment.
Aurein-induced membrane leakage in S. aureus,
using DiSC35 assays
Antimicrobial peptides can kill bacteria through many
different mechanisms in which cytoplasmic membrane
depolarization is a common target site. To observe the
effects of aurein peptides on the cytoplasmic membrane
of S. aureus C622, we performed membrane-depolarization
experiments using the membrane-sensitive dye DiSC35.
All peptides were compared with the membrane perturbing
cyclic peptide gramicidin S. Fig. 7 shows that at 1–5 times
the MIC, aurein 2.2 demonstrated greater depolarization of
the membrane than any of the other peptides, including
gramicidin S. Aurein 2.3 demonstrated similar depolariza-
tion to gramicidin S at 1  MIC, whereas aurein 2.3-
COOH was much less efficient than gramicidin S.
Increasing the level of aurein peptide added to 5  MIC
showed an increased depolarization affect for both
amidated peptides.
DISCUSSION
Understanding how membrane composition modulates
peptide-lipid interactions can be an important step in unlocking
the mechanism of action of a given antimicrobial peptide.
Here, we further examined how two antimicrobial peptides
from the Australian southern bell frog Litoria aurea, i.e., aur-
ein 2.2 and aurein 2.3, interact with a range of model
membranes and the membrane from S. aureus C622. As
a negative control, we also investigated the peptide-lipid inter-
action of a nonactive analog, aurein 2.3-COOH.
The bacterial membrane composition varies from bacte-
rium to bacterium, and also as a response to changing envi-
ronments (68,69) and exposure to antibiotics (70–72).
Phosphatidyl-ethanolamine is known as a major membrane
component (up to 80%) in Gram-negative bacteria (72–74),
whereas PG is identified as a major membrane component
(up to 58%) in Gram-positive bacteria (75–78). Incorpo-
rating PG in model membranes is thus necessary to repli-
cate the lipid bilayers of Gram-positive bacteria. Previous
studies were often conducted in model membranes with
a 33% or 50% molar PG content (14,43,64,79–82). The
DMPC/DMPG bilayers (19,56,57,64,79,81) and POPC/
POPG bilayers (14,19,43,80,83) are the most commonly
used bacterial membrane models. Other models include
PG only, or mixtures of DOPC/DOPG (84,85) or DPPC/
DPPG (57,86,87), to account for different bilayer thick-
nesses and fluidities. Our study involved the most widely
used models, i.e., DMPC/DMPG (~26 A˚) (55) and POPC/
POPG (~39 A˚) (57) bilayers, to determine whether bilayer
thickness or PG content exerts an effect on aurein peptide-
lipid interactions.
It is widely accepted that cationic antimicrobial peptides
only adopt secondary structures in the presence of
membranes (1,58,88), and that the adoption of a secondary
structure is a key first step toward membrane interaction.
Our solution CD results showed that the structures of the
three aurein peptides were similar in the presence of 1:1
DMPC/DMPG (36) and, as demonstrated here, in 3:1
DMPC/DMPG. Maculatin 1.1 and citropin 1.1, a-helical
antimicrobial peptides from tree frogs, were also shown to
retain their structures in DMPC, DMPG, POPC, and
POPG membranes (19,89). We demonstrated here, however,
that helical content depends on membrane bilayer thickness,
with differences in percent a-helical structure between
DMPC/DMPG and POPC/POPG. This finding demonstrates
that secondary structure is independent of PG content, but
depends on bilayer thickness. In other words, membrane
bilayer thickness appears to have an effect on the ability of
a peptide to bind the membrane and, consequently, to have
an effect on the ability of a lipid bilayer to induce peptide
secondary structures.
Many studies demonstrated how electrostatics and
bilayer thickness play an important role in peptide-lipid
FIGURE 6 (a) Calcein release spectra of 3:1 DMPC/DMPG (mol/mol) (top), and 1:1 (middle) and 3:1 POPC/POPG (mol/mol) (bottom) SUVs in the pres-
ence of aurein 2.2 (black solid line), aurein 2.3 (black dotted line), and aurein 2.3-COOH (gray solid line) at a 1:15 peptide/lipid molar ratio. (b) Percentage of
calcein released from 1:1 (top) and 3:1 POPC/POPG (mol/mol) (bottom) SUVs in the presence of aurein 2.2 (black solid line), aurein 2.3 (black dotted line),
and aurein 2.3-COOH (gray solid line) as a function of peptide/lipid molar ratio.
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FIGURE 7 Membrane depolarization of S. aureus C622 induced by aur-
ein 2.2 at 1  MIC and 5  MIC; aurein 2.3 at 1 MIC and 5  MIC; and
aurein 2.3-COOH at 1  MIC. MIC values are described elsewhere (36).
Gramicidin S (1  MIC) was used as control. Results are representative
of 2–3 experiments. Arrow represents time when peptide was added.
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interactions (14,43–45,64,90). In the latter case, it was
generally shown that longer antimicrobial peptides, e.g.,
caerin 1.1 and maculatin 1.1 (19), insert more readily into
lipid bilayers, and undergo less impact from increased
bilayer thickness. On the other hand, shorter antimicrobial
peptides insert less readily, and compensate by inserting
into only one leaflet, or by tilting to minimize hydrophobic
mismatch. In addition, it was recently shown that the tilt of
helices, which increases with decreasing bilayer thickness
and has an impact on the ability of a peptide to oligomerize
(91), is not necessarily accompanied by a change in the
phase, order, or structure of lipid bilayers (92). In this
study, a clear difference in the insertion profile of aurein
peptides was observed as a function of bilayer thickness.
In the thinner DMPC/DMPG bilayers, much lower concen-
trations of amidated peptides were required for insertion
(P/L, ~1:200 for 1:1 DMPC/DMPG). In POPC/POPG bila-
yers, higher aurein peptide concentrations were required to
produce a change from the surface-adsorbed state to the in-
serted or tilted state. From a different view, one might argue
that the thinner DMPC/DMPG membranes result in a larger
portion of peptides interacting with the entire lipid mole-
cules (headgroups and chains), resulting in more membrane
disruption, as shown in Fig. 8 a, and as evidenced by the
31P NMR, DSC, and calcein data. In the case of POPC/
POPG membranes (Fig. 8 b), aurein peptides may be forced
to interact comparatively more with the surface, resulting in
a toroidal pore or related (i.e., distorted toroidal or localized
membrane aggregate) mechanism, where the lipid head-
groups are perturbed (as seen in the 31P NMR data), but
not the lipid acyl chains (as seen in DSC data). Because
many more peptides in this case would be required to
line the defects in the membrane bilayers (15,58–61), the
amount of calcein released for a given P/L ratio should
562be lower than in a case where micellerization occurs
(Fig. 8).
In terms of electrostatics, the increase in the amount of PG
in DMPC/DMPG bilayers clearly has the effect that fewer
peptides are required to promote insertion into the
membrane. Indeed, the threshold P/L ratio in 1:1 DMPC/
DMPG was ~1:200, whereas in 3:1 DMPC/DMPG, it was
between 1:40 and 1:80. Presumably the increased negative
charge in 1:1 DMPC/DMPG favored the binding of aurein
peptides to the surface, enabling them to insert and perturb
the membrane bilayers more readily. In the case of POPC/
POPG, the increased negative charge in the case of 1:1 vs.
3:1 resulted in a more complex effect and insertion profile.
Here, the increased PG content had the effect of differenti-
ating the behavior of aurein 2.2 from that of aurein 2.3
and from that of aurein 2.3-COOH. Presumably in the
case of POPC/POPG, where distorted toroidal pores or
localized membrane aggregates might be formed, and
peptides might pack (or aggregate?) to line these defects,
not only would peptide-lipid electrostatic interactions be
important, but also peptide-peptide electrostatic interactions.
A number of studies showed that Leu is more hydrophobic
in peptides than Ile (93–96), suggesting that aurein 2.2
would more likely aggregate. To verify whether aurein 2.2
is more likely to form oligomers in solution, the retention
times of aurein 2.2 and aurein 2.3 on a reverse-phase
high-performance liquid chromatography were determined.
Pure peptides were injected and eluted under a gradient of
water/acetonitrile, as used to purify the crude peptides (see
Materials and Methods). The retention times for both peptides
were nearly identical, indicating that both peptides behave the
same way in solution. To probe further whether aurein 2.2 has
a higher propensity to oligomerize in membranes, nuclear
Overhauser effect spectroscopy (NOESY) spectra were
Cheng et al.FIGURE 8 General model for pertur-
bation of (a) DMPC/DMPG and (b)
POPC/POPG by aurein peptides. To
keep the model simple, some finer
points, such as distinction in ability of
aurein 2.2 to induce membrane depolar-
ization in S. aureus C622 compared
with aurein 2.3 and aurein 2.3-COOH,
are obviously not taken into account.
Arrows represent leakage.
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micelles, and for aurein 2.3 under the same conditions.
Preliminary data suggests that aurein 2.2 forms dimers in
DPC micelles, because of the larger number of long-range
NOE crosspeaks found, as reported for MSI-78 (37).
A comparison of calcein-release and DiSC35 data clearly
shows the merits and limitations of using model
membranes. By using the same model membranes in the
calcein release assay as in the other experiments (OCD,
31P NMR, and DSC), a comprehensive model of the inter-
actions of aurein peptides with well-defined DMPC/
DMPG and POPC/POPG membranes can be elucidated.
For instance, the calcein data clearly show that all three aur-
ein peptides are equally efficient at perturbing 3:1 DMPC/
DMPG liposomes, a finding supported by the OCD, 31P
NMR, and DSC data. The calcein release data also demon-
strate that aurein 2.2 is better at inducing leakage at high
concentrations, compared with the other two peptides, a
finding supported by the DiSC35 data. On the other hand,
the calcein data suggest that the inactive aurein 2.3-COOH
is more efficient at perturbing both 1:1 and 3:1 POPC/
POPG liposomes than the amidated version, a finding clearly
unsupported by much of the other data, and especially by
the biological data, which are consistent with the inactivity
of this peptide.
Overall, the results presented here suggest that aurein
peptides interact with membranes in a manner that is depen-
dent on lipid composition and on sequence. The DiSC35
data show that aurein 2.2 is better at inducing membrane
depolarization than aurein 2.3, which is itself as efficient
as gramicidin S. The OCD data of the three peptides in
the 1:1 POPC/POPG model membranes show similar
distinction in the behavior of the peptides, suggesting that
perhaps this lipid composition is optimal for studying this
subset of the aurein peptide family. Finally, if one assumes
that the 1:1 POPC/POPG membranes are the most relevant,
and that the peptides function by inducing distorted toroidal
pores or localized membrane aggregates, then the sequence
dependence observed in the DiSC35 results may be related
to differences in the potential of aurein 2.2 to form oligo-
mers relative to the other two peptides, but only in the
membrane.
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